JSM 2014 Home
Online Program Home
My Program

Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.

Activity Details

492 * ! Wed, 8/6/2014, 10:30 AM - 12:20 PM CC-254B
Approaches for Benefit-Risk Assessment in Clinical Development Decisionmaking — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Weili He, Merck
Chair(s): Weili He, Merck   
10:35 AM Using Endpoint Data to Analyze Patients Rather Than Patient Data to Analyze the Endpoints Scott R. Evans, Harvard School of Public Health
10:55 AM Using Decision Analysis to Regulate Medical Devices Xuefeng Li, FDA ; Telba Z. Irony, Center for Devices and Radiological Health ; Martin Ho, FDA
11:15 AM Communicating Benefit-Risk Analysis Results Using Graphics Richard Forshee, FDA
11:35 AM Weight in Benefit-Risk Evaluation Yabing Mai, Merck ; Weili He, Merck
11:55 AM Discussant: Jerald Schindler, Merck
12:15 PM Floor Discussion

2014 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Professional Development program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.